£2.3M R&D Tax Credit from UK Government Cyclacel Pharmaceuticals Reaps Financial Reward According to Seeking Alpha, Cyclacel Pharmaceuticals listed on NASDAQ as CYCC got good news for its money matters. They received a hefty £2.3 million (about $2.9 million) as a Research and Development (R&D) tax credit from the UK government’s tax agency HMRC. This … Read more